Kay NE - Search Results

1

Prognostic significance of the S-phase fraction of light-chain-restricted cytoplasmic immunoglobulin (cIg) positive plasma cells in patients with newly diagnosed multiple myeloma enrolled on Eastern Cooperative Oncology Group treatment trial E9486.

Trendle MC, Leong T, Kyle RA, Katzmann JA, Oken MM, Kay NE, Van Ness BG, Greipp PR. Trendle MC, et al. Among authors: kay ne. Am J Hematol. 1999 Aug;61(4):232-7. doi: 10.1002/(sici)1096-8652(199908)61:4<232::aid-ajh2>3.0.co;2-t. Am J Hematol. 1999. PMID: 10440908 Free article.

2

Chronic lymphocytic leukemia in association with a second lymphoproliferative disorder: response to chemotherapy in two cases.

Gordon LI, Hrushesky W, Oken MM, Kay NE, Rydell RE. Gordon LI, et al. Among authors: kay ne. Med Pediatr Oncol. 1979;7(2):111-6. doi: 10.1002/mpo.2950070203. Med Pediatr Oncol. 1979. PMID: 388174

3

Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients.

Billadeau D, Quam L, Thomas W, Kay N, Greipp P, Kyle R, Oken MM, Van Ness B. Billadeau D, et al. Blood. 1992 Oct 1;80(7):1818-24. Blood. 1992. PMID: 1391945 Free article.

4

B-chronic lymphocytic leukemia cells contain both endogenous kappa immunoglobulin mRNA and critical immunoglobulin gene activation transcription factors.

Zaknoen SL, Christian SL, Suen R, Van Ness B, Kay NE. Zaknoen SL, et al. Among authors: kay ne. Leukemia. 1992 Jul;6(7):675-9. Leukemia. 1992. PMID: 1625486

5

Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease.

Billadeau D, Blackstadt M, Greipp P, Kyle RA, Oken MM, Kay N, Van Ness B. Billadeau D, et al. Blood. 1991 Dec 1;78(11):3021-9. Blood. 1991. PMID: 1954387 Free article.

6

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group.

Cheson BD, Bennett JM, Rai KR, Grever MR, Kay NE, Schiffer CA, Oken MM, Keating MJ, Boldt DH, Kempin SJ, et al. Cheson BD, et al. Among authors: kay ne. Am J Hematol. 1988 Nov;29(3):152-63. doi: 10.1002/ajh.2830290307. Am J Hematol. 1988. PMID: 3189311

7

Evidence for tumor reduction in refractory or relapsed B-CLL patients with infusional interleukin-2.

Kay NE, Oken MM, Mazza JJ, Bradley EC. Kay NE, et al. Nouv Rev Fr Hematol (1978). 1988;30(5-6):475-8. Nouv Rev Fr Hematol (1978). 1988. PMID: 3265509

8

Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study.

O'Connell MJ, Colgan JP, Oken MM, Ritts RE Jr, Kay NE, Itri LM. O'Connell MJ, et al. Among authors: kay ne. J Clin Oncol. 1986 Feb;4(2):128-36. doi: 10.1200/JCO.1986.4.2.128. J Clin Oncol. 1986. PMID: 3511183 Clinical Trial.

9

Simultaneous presentation of relapsing Hodgkin's disease and treatment-related non-Hodgkin's lymphoma.

Perri RT, Allen JI, Oken MM, Limas C, Kay NE. Perri RT, et al. Among authors: kay ne. Med Pediatr Oncol. 1985;13(3):122-5. doi: 10.1002/mpo.2950130303. Med Pediatr Oncol. 1985. PMID: 3838792

10

Lymphocytotoxic T lymphocytes in a patient with B-chronic lymphocytic leukemia and pure red cell aplasia.

Kay NE, Oken MM, Ascensao J, Kaplan ME. Kay NE, et al. Leuk Res. 1985;9(9):1189-94. doi: 10.1016/0145-2126(85)90110-9. Leuk Res. 1985. PMID: 3877853

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

471 results

Search Page

Filters